Learn more

KABI PHARMACIA AB

Overview
  • Total Patents
    546
About

KABI PHARMACIA AB has a total of 546 patent applications. Its first patent ever was published in 1977. It filed its patents most often in WIPO (World Intellectual Property Organization), Sweden and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ELILILLY AND COMPANY, PHARMACIA & UPJOHN AB and PHARMACIA AB.

Patent filings per year

Chart showing KABI PHARMACIA ABs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Hjertman Birger 40
#2 Ljungquist Olle 35
#3 Levander Gustav 26
#4 Lind Peter 25
#5 Resul Bahram 20
#6 Lake Mats 20
#7 Fryklund Linda 19
#8 Haraldsson Martin 18
#9 Holmgren Erik 17
#10 Ahrgren Leif 17

Latest patents

Publication Filing date Title
US5691350A Use of linomide for treatment of retrovirus infections specifically HIV infections
US5661008A Recombinant human factor VIII derivatives
US5516796A Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof
ZA9402035B Protein formulation
WO9419186A1 Autoclavable multilayer films
CA2113795A1 Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
LTIP1632A New antibody-superantigen conjugates, process for preparing thereof, process for target cell lysis and use of conjugates in pharmaceutical compositions
WO9407920A1 Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof
WO9407510A1 Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer
ZA9307266B Composition comprising coagulation factor VIII formulation process for its preparation and use of a surfactant as stabilizer
US5310913A Derivatives of quinoline-3-carboxanilide
ZA9305045B Pharmacologically active alfa-(tertiary-aminomethyl)-ben-zenemethanol derivatives
GB9313221D0 Use of human igf-ii
WO9400434A1 Novel nicotinic acid esters
KR100276374B1 Dual-chamber injection cartridge
WO9321911A1 Method and means for preventing constriction of the pupil in the eye
WO9320869A1 Injection device
AU4273893A Injection cartridge arrangement
NZ251498A Injectable formulations of human growth hormone and citrate buffer
CA2091152A1 Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof